BIA
KRYS icon

Biondo Investment Advisors’s Krystal Biotech KRYS Stock Holding History

Biondo Investment Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4M Sell
70,945
-1,100
-2% -$329K 3.23% 8
2026
Q1 		$18.6M Buy
72,045
+3,915
+6% +$1.04M 2.39% 10
2025
Q4 		$16.8M Buy
68,130
+16,245
+31% +$3.42M 2.03% 14
2025
Q3 		$9.16M Buy
51,885
+30,645
+144% +$4.59M 1.15% 33
2025
Q2 		$2.92M Buy
+21,240
New +$3.12M 0.38% 47

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Biondo Investment Advisors's KRYS Position: Q2 2026 in Review

Biondo Investment Advisors reduced its Krystal Biotech (KRYS) stake by 1.5% in Q2 2026, selling an estimated $329K and leaving 70,945 shares worth $26.4M. The position accounts for 3.23% of the portfolio, ranked #8.

Biondo Investment Advisors first reported a position in KRYS in Q2 2025 and has held it in 5 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Biondo Investment Advisors held 70,945 shares of Krystal Biotech worth $26.4M as of Q2 2026.
  • Biondo Investment Advisors sold 1,100 Krystal Biotech shares in Q2 2026, an estimated $329K.
  • Krystal Biotech made up 3.23% of Biondo Investment Advisors's portfolio in Q2 2026, its #8 holding.
  • Biondo Investment Advisors first reported a position in Krystal Biotech in Q2 2025 and has held it in 5 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Biondo Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.